NCATS Seeks New NIH Intramural Research Collaborations
An Array of Programs to Speed Up Process for Translating Discoveries into New Drugs
BY NCATS STAFF
Intramural scientists at the National Center for Advancing Translational Sciences (NCATS) develop, demonstrate, and disseminate new technologies that aim to speed up the process for translating discoveries into approved new drugs. (Typically, it can take about 14 years, costs about $2 billion, and has a failure rate exceeding 95 percent.) NCATS offers an array of funding programs and in-kind support services designed to help researchers translate basic scientific knowledge into interventions that improve human health.
This winter, construction will commence on the Medical Center Metro Crossing Project. Expected to be completed in 2018, the project adds a shallow, underground east-west pedestrian crosswalk that will connect the Medical Center Metro Station and the NIH side of Rockville Pike to the opposite side, where Walter Reed Medical Center and the rest of the Naval Support Activity–Bethesda campus (NSAB) are located.
The first president to visit NIH in Bethesda was the one responsible for its construction there—Franklin D. Roosevelt. On October 31, 1940—75 years ago this fall—he dedicated the campus, speaking on the patio of Building 1.
Here at Felcom we take a break from our monthly meetings over the summer and begin again in the fall when everyone is gearing back up for new semesters. So now is the perfect time to introduce ourselves to those who are new or unfamiliar with Felcom. Felcom is the Fellows Committee here at NIH, and it is dedicated to improving the experience of every fellow on all NIH campuses.